PancreatectomyDiabetes Mellitus Type 2Pancreatic Neoplasms
Study summary
This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.
The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.
Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection.
Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult patients (≥18 years)
* No diabetes mellitus at baseline
* Undergoing partial, near-total, or total pancreatectomy at the study center
* Availability of clinical and metabolic data according to study component
* Written informed consent for the prospective component
Exclusion Criteria:
* Diabetes mellitus at baseline
* Age \<18 years
* Missing key clinical data precluding eligibility assessment or primary outcome evaluation
* Refusal or inability to provide informed consent for the prospective component, where applicable
Primary outcome measure(s)
Incidence of New-Onset Diabetes Mellitus After Pancreatectomy — Within 12 months after surgery Incidence of new-onset diabetes mellitus in participants without diabetes at baseline according to the type of pancreatic resection.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
